The Shift from Creatinine Clearance to Race-Free eGFR
From CEimpact Podcast · · 52 min
This plays from the publisher's own server. We do not host a copy.
Description
Kidney function estimates influence medication dosing, safety, and monitoring decisions across pharmacy practice. This course reviews the shift from Cockcroft-Gault estimated creatinine clearance (CrCl) to the 2021 CKD-EPI race-free estimated glomerular filtration rate (eGFR) equation and what the change means for pharmacy practice. You will be better prepared to use race-free eGFR in medication-related decisions.
HOST Rachel Maynard, PharmD GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact
GUEST Andrew Bzowyckyj, PharmD, BCPS, CDCES Senior Scientific Director, Learning Consultant National Kidney Foundation
GET CE FOR LISTENING! Stay Compliant. Grow Clinically. Practice with Confidence.
Purchase a CE Subscription (https://www.ceimpact.com/courses/subscriptions/) to get CE credit for this episode.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update are included with a Pharmacist or Technician CE Subscription. But wait…there’s even more!
The Pharmacist & Technician CE Subscriptions (https://www.ceimpact.com/courses/subscriptions/) include: - Compliance and licensure CE - GameChangers Clinical Updates - Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
CEimpact's CE Subscriptions: All your CE in one convenient subscription. Purchase Now! (https://www.ceimpact.com/courses/pharmacist-subscription/)
PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing a Pharmacist or Technician CE Subscription (https://www.ceimpact.com/courses/subscriptions/).
CPE REDEMPTION This course is accredited for continuing pharmacy education!
If you have a CE Subscription and are ready to claim credit, click the link below for your practice role:
- PHARMACIST CE (https://learn.ceimpact.com/login?redirUrl=/course-landing/11071)
- TECHNICIAN CE (https://learn.ceimpact.com/login?redirUrl=/course-landing/11074)
If you do not have a CE Subscription, click here (https://www.ceimpact.com/courses/subscriptions/) to purchase and claim credit for this episode!
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the rationale for transitioning from Cockcroft-Gault estimated creatinine clearance to race-free eGFR for medication-related decision-making. 2. Explain practical considerations for using race-free eGFR in medication-related decisions.
Rachel Maynard and Andrew Bzowyckyj have no relevant financial relationships to disclose.
0.1 CEU/1.0 Hr UAN: 0107-0000-26-376-H01-P/T Initial release date: 11/16/2026 Expiration date: 11/16/2029 Additional CPE details can be found here (https://www.ceimpact.com/courses/the-shift-from-creatinine-clearance-to-race-free-eGFR) for pharmacists and here (https://www.ceimpact.com/courses/the-shift-from-creatinine-clearance-to-race-free-eGFR-2) for pharmacy technicians.
Follow CEimpact on Social Media: LinkedIn (https://www.linkedin.com/company/ceimpact) Instagram (https://www.instagram.com/ceimpactrx/)